Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series

OBJECTIVE: To assess the real-world effectiveness and safety of single injection of a fluocinolone acetonide (FAc) implant in previously treated patients with recurrent diabetic macular oedema (DMO) over a 36-month follow-up period. METHODS AND ANALYSIS: This is a retrospective study conducted at a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Ophthalmol
Main Authors: Ahmed, Muna, Putri, Christine, Quhill, Hibba, Quhill, Fahd
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7337879/
https://ncbi.nlm.nih.gov/pubmed/32656358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2020-000484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados